
There is ample mounting evidence that zzso zzso species are exacerbated in inflammatory zzso many pathological conditions, and underlying processes of chronic age-related zzso Therefore there is increased expectation that zzso can be developed that act in some fashion to suppress zzso zzso species and zzso the zzso This has turned out to be more difficult than at first zzso zzso zzso for indications in which zzso zzso species are an important consideration presents some unique zzso We discuss important questions including whether zzso zzso species should be a therapeutic target, the need to recognize the fact that an zzso in a defined chemical system may be a poor zzso zzso in a biological system, and the importance of considering that zzso zzso species may accompany the disease or pathological system rather than being a zzso zzso We also discuss the value of having zzso models to determine if the processes that are important in causing the disease under study are critically dependent on zzso zzso species events and if the therapeutic under consideration zzso these zzso In addition we discuss measures of success that must be met in commercial research and development and in zzso and clinical trials and discuss as examples our zzso research effort in developing zzso for the treatment of acute zzso stroke and as zzso zzso 

